Keywords: Metronomic; Breast cancer; Vinorelbine;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CTD; connective tissue diseases; LC; lung cancer; SLE; systemic lupus erythematosus; PM/DM; polymyositis/dermatomyositis; SSc; systemic sclerosis; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; PS; performance
Keywords: Vincristine; vinblastine; vinorelbine; chlorine; transformation products; water samples;
Keywords: Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: eribulin; capecitabine; gemcitabine; metastatic breast cancer; triple negative; vinorelbine;
Keywords: NSCLC; CCRT; Vinorelbine; JNK; CeramideNSCLC, non-small cell lung cancer; CCRT, concurrent chemoradiotherapy; VNR, vinorelbine; JNK, c-Jun N-terminal kinase; CT, chemotherapy; RT, radiotherapy; NAC, N-acetyl-L-cysteine
Keywords: LN; lymph node; Vin; vinorelbine; Dox; doxorubicin; ICG; indocyanine green; Axi; axillary; Ing; inguinal; Mes; mesentery; i.v; intravenous; PEG-PE; distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000]; Lymphatic drug delivery
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
Keywords: Bone metastases; Hormone sensitive; Metastatic breast cancer; Oral chemotherapy; Vinorelbine;
Vincristine-loaded liposomes prepared by ion-paring techniques: Effect of lipid, pH and antioxidant on chemical stability
Keywords: VCR; vincristine; VLB; vinblastine; VRB; vinorelbine; CHEMS; cholesteryl hemisuccinate; VIP; VCR-CHEMS ion-pair complex; VIPL; VCR-CHEMS ion-pair complex liposomes; VCRS; vincristine aqueous solution; HSPC; hydrogenated soybean phosphatide; DPPC; dipalmit
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic Pregnancy
Keywords: Ectopic pregnancy; Vinorelbine; Methotrexate; Placenta; Treatment;
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study
Keywords: Hematopoietic progenitor cell mobilization; Chemomobilization; Vinorelbine; Filgrastim; Multiple myeloma; Autologous stem cell transplantation;
Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
Keywords: ABCG2; ATP-binding cassette sub-family G member 2; CI; combination index; D-VNR; deacetyl-vinorelbine; EGFR; epidermal growth factor receptor; FBS; fetal bovine serum; IC50; inhibitory concentration 50; mVNR; metronomic vinorelbine; NSCLC; Non Small Cell
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1
Keywords: LC; lung cancer; ILD; interstitial lung disease; HRCT; high-resolution computed tomography; AE; acute exacerbation; DAD; diffuse alveolar damage; IPF; idiopathic pulmonary fibrosis; PS; performance status; ECOG; Eastern Cooperative Oncology Group; NSCLC;
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort study
Keywords: Breast neoplasms; Cohort studies; Palliative care; Outpatients; Real-world data; Registries; ABC; advanced breast cancer; AGO; Arbeitsgemeinschaft Gynäkologische Onkologie; Bev; bevacizumab; C; cyclophosphamid; Cap; capecitabine; Car; carboplatin; CCI; C
Oral versus intravenous vinorelbine in advanced NSCLC-a retrospective comparison
Keywords: NSCLC; Vinorelbine; Non-small cell lung cancer; Oral vinorelbine; Carboplatin; Intravenous;
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer
Keywords: Breast cancer; HER2; Lapatinib; Vinorelbine; Capecitabine; Overall survival;
Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-s
Keywords: NSCLC; Sequential treatment; Bevacizumab; Overall response rate; Vinorelbine; Cisplatin;
Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma
Keywords: Malignant pleural mesothelioma; Vinorelbine; Vinflunine; Vinca alkaloids; Chemotherapy;
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10
Keywords: Platinum resistant; Ovarian cancer; Gemcitabine; Vinorelbine;
MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells
Keywords: NVB; Vinorelbine; KEGG; Kyoto Encyclopedia of Genes and Genomes; GO; Gene Ontology; PPI; protein-protein interaction, miRNA, microRNA; miR; microRNA; RT-qPCR; real-time quantitative PCR; DMEM; Dulbecco's modified Eagle's medium; MTT; 3-(4,5-dimethylthia
Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment
Keywords: MM; multiple myeloma; HDCT; high-dose chemotherapy; ASCT; autologous stem cell transplantation; G-CSF; granulocyte-colony stimulating factor; PN; peripheral neuropathy; CIPN; chemotherapy-induced peripheral neuropathy; BIPN; bortezomib-induced peripheral
Efficacy of Vinorelbine Plus Granulocyte Colony–Stimulation Factor for CD34+ Hematopoietic Progenitor Cell Mobilization in Patients with Multiple Myeloma
Keywords: Hematopoietic progenitor cell mobilization; Chemo-mobilization; Vinorelbine; Multiple myeloma; Lenalidomide
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
Keywords: Anti-angiogenesis; Metronomic; Vinorelbine; Sorafenib; NSCLC; Biomarkers;
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)
Keywords: Oral chemotherapy; Older patients; Breast cancer; Lung cancer; Colorectal cancer; Metronomic therapy; Vinorelbine; Capecitabine; Bevacizumab
Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
Keywords: Mesothelioma; Vinorelbine; Gemcitabine; Chemotherapy
A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): Paclitaxel plus carboplatin versus vinorelbine plus cisplatin
Keywords: Adjuvant chemotherapy; Vinorelbine; Cisplatin; Non-small cell lung cancer; Paclitaxel; Carboplatin;
Validated HILIC–MS/MS assay for determination of vindesine in human plasma: Application to a population pharmacokinetic study
Keywords: Vindesine; Vinorelbine; HILIC; MS/MS; Pharmacokinetics
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
Keywords: Malignant pleural mesothelioma; Chemotherapy; Second or further-line; Pemetrexed-pretreated patients; Vinorelbine; Activity and toxicity
Phase I/II Trial of Vinorelbine and Sorafenib in Metastatic Breast Cancer
Keywords: Bevacizumab; Kinase inhibitor; Metastatic breast cancer; Sorafenib; Vinorelbine;
Fractionated Scheme of Oral Vinorelbine as Single-Agent Therapy or in Combination With Cisplatin Concomitantly With Thoracic Radiotherapy in Stage III Non–Small-Cell Lung Cancer: Dose-Escalation Phase I Trial
Keywords: Locally advanced; NSCLC; Radiotherapy; Vinorelbine
Oral Vinorelbine Plus Cisplatin as First-Line Chemotherapy in Nonsquamous Non–Small-Cell Lung Cancer: Final Results of an International Randomized Phase II Study (NAVotrial 01)
Keywords: Advanced non–small-cell lung cancer; Chemotherapy; Nonsquamous histologic subtype; Pemetrexed; Vinorelbine
Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis
Keywords: VNR; vinorelbine; SIRT1; sirtuin 1; AMPK; AMP-activated protein kinase; PKC; protein kinase C; LKB1; protein liver kinase B1; TAK1; TGF-β-activated kinase-1; TAB1; TAK-binding protein-1; ROS; reactive oxygen species; DCF-AM; 2â²,7â²-dichlorofluorescein
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial
Keywords: HER2 positive; Lapatinib; Metastatic breast cancer; Vinorelbine;
Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601
Keywords: UFT; Vinorelbine; Cisplatin; Chemoradiotherapy; Locally advanced; Non-small-cell lung cancer; Randomized phase II trial
Development of intravenous lipid emulsion of vinorelbine based on drug–phospholipid complex technique
Keywords: Vinorelbine; Drug–phospholipid complex; Injection irritation; Antitumor activity
Simultaneous quantification of vinblastine and desacetylvinblastine concentrations in canine plasma and urine samples using LC–APCI–MS/MS
Keywords: Vinblastine; Desacetylvinblastine; Vinorelbine; Dog; LC/MS/MS; Analysis
Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: A case series and review of the literature
Keywords: Bladder cancer; Small-cell carcinoma; Metastasis; Vinorelbine
Reversible Posterior Leukoencephalopathy Syndrome Induced by Vinorelbine
Keywords: Breast cancer; Chemotherapy; Reversible posterior leukoencephalopathy syndrome; Vinorelbine;
Synthesis and structure-activity relationship studies of cytotoxic vinorelbine amide analogues
Keywords: Vinorelbine; C-22 amide analogues; Tubulin inhibitor; Structure-activity relationship (SAR); Cytotoxicity;
Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non–Small-Cell Lung Cancer
Keywords: Carboplatin; Elderly patients; Non–small-cell lung cancer; Vinorelbine
Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: A retrospective study in Japan
Keywords: Non-small-cell lung cancer; Adjuvant chemotherapy; Cisplatin; Vinorelbine; Feasibility;
Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
Keywords: Capecitabine; Combination chemotherapy; Metastatic breast cancer; Trastuzumab; Vinorelbine
Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
Keywords: Gemcitabine; Vinorelbine; Nasopharyngeal carcinoma; Platinum-based chemotherapy; Salvage chemotherapy;
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working
Keywords: Cisplatin; Gemcitabine; Induction chemotherapy; Non-small cell lung carcinoma; Randomised trial; Surgery; Vinorelbine;
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma - A report from the Société Française des Ca
Keywords: BSA; Body Surface Area; BE; bioequivalence; NS; non significatif; AUC; Area under curve; NE; non evaluable; Phase II; Vinorelbine; Cyclophosphamide; Metronomic; Rhabdomyosarcoma; PK;
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell line
Keywords: Medullary thyroid cancer; Celecoxib; Vinorelbine; Tyrosine kinase inhibitors; Chemotherapy;
Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials
Keywords: Capecitabine; Metastatic breast cancer; Oral chemotherapy; Vinorelbine
Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial
Keywords: Elderly; SCLC; Gemcitabine; Vinorelbine; Etoposide; Platinum compounds
Therapie des nicht-resektablen malignen Pleuramesothelioms
Keywords: Malignes Pleuramesotheliom (MPM); Asbest; Pemetrexed-Platin-Zweifachtherapie; Vinorelbine; Gemcitabine; Talkumpleurodese; palliative DekortikationMesothelioma; malignant pleural mesothelioma (MPM); asbestos; pemetrexed-cisplatinum combination; pleural eff
A Phase II Study of Lipoplatin (Liposomal Cisplatin)/Vinorelbine Combination in HER-2/neu-Negative Metastatic Breast Cancer
Keywords: Breast cancer; Lipoplatin; Metastatic; Toxicity; Vinorelbine;